Latest Insider Transactions at Eloxx Pharmaceuticals, Inc. (ELOX)
This section provides a real-time view of insider transactions for Eloxx Pharmaceuticals, Inc. (ELOX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Eloxx Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Eloxx Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 16
2024
|
Sumit Aggarwal PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
165,000
+49.26%
|
-
|
|
Oct 16
2024
|
Steven D Rubin Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+50.0%
|
-
|
|
Oct 16
2024
|
Lindsay Androski Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+50.0%
|
-
|
|
Oct 16
2024
|
Alan Edmund Walts Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,000
+48.11%
|
-
|
|
Dec 01
2021
|
Vijay Modur HEAD OF R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
64,373
-29.35%
|
$0
$0.72 P/Share
|
|
Dec 01
2021
|
Vijay Modur HEAD OF R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
219,326
+50.0%
|
-
|
|
Dec 01
2021
|
Sumit Aggarwal PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
81,933
-29.35%
|
$0
$0.72 P/Share
|
|
Dec 01
2021
|
Sumit Aggarwal PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
279,158
+50.0%
|
-
|
|
Dec 01
2021
|
Alan Edmund Walts Director |
BUY
Exercise of conversion of derivative security
|
Direct |
37,695
+50.0%
|
-
|
|
Nov 29
2021
|
Daniel E. Geffken INTERIM CFO |
BUY
Open market or private purchase
|
Direct |
50,000
+50.0%
|
$0
$0.72 P/Share
|
|
Jul 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-1.38%
|
$459
$1.32 P/Share
|
|
Jul 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+4.5%
|
-
|
|
May 25
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,835
-5.49%
|
$1,835
$1.39 P/Share
|
|
May 25
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+15.75%
|
-
|
|
May 13
2021
|
Tomer Kariv Director |
BUY
Open market or private purchase
|
Indirect |
5,925,925
+43.52%
|
$5,925,925
$1.35 P/Share
|
|
May 13
2021
|
Ran Nussbaum Director |
BUY
Open market or private purchase
|
Indirect |
5,925,925
+43.52%
|
$5,925,925
$1.35 P/Share
|
|
May 13
2021
|
Pontifax Management 4 G.P. (2015) Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
5,925,925
+43.52%
|
$5,925,925
$1.35 P/Share
|
|
May 13
2021
|
Rajesh B Parekh Director |
BUY
Open market or private purchase
|
Indirect |
2,466,666
+33.04%
|
$2,466,666
$1.35 P/Share
|
|
Apr 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-1.66%
|
$918
$2.18 P/Share
|
|
Apr 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+5.35%
|
-
|
|
Apr 01
2021
|
Rajesh B Parekh Director |
BUY
Grant, award, or other acquisition
|
Indirect |
2,532,270
+50.0%
|
-
|
|
Feb 25
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
15,360
-25.6%
|
$46,080
$3.95 P/Share
|
|
Feb 25
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+45.46%
|
-
|
|
Feb 25
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
7,338
-21.96%
|
$22,014
$3.95 P/Share
|
|
Feb 25
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+42.8%
|
-
|
|
Jan 30
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-6.05%
|
$1,929
$3.44 P/Share
|
|
Jan 30
2021
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+14.99%
|
-
|
|
Jan 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
542
-6.05%
|
$1,626
$3.44 P/Share
|
|
Jan 30
2021
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,563
+14.86%
|
-
|
|
Oct 30
2020
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-5.84%
|
$918
$2.53 P/Share
|
|
Oct 30
2020
|
Neil S. Belloff COO, GENERAL COUNSEL &CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
1,562
+16.59%
|
-
|
|
Oct 30
2020
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
625
-6.66%
|
$1,250
$2.53 P/Share
|
|
Oct 30
2020
|
Gregory C. Williams CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,875
+16.66%
|
-
|